Clinical Pharmacokinetics of Doxycycline and Minocycline

Overview

Journal Clin Pharmacokinet

Specialty Pharmacology

Date 1988 Dec 1

PMID 3072140

Citations 114

Authors

S Saivin

G Houin

Affiliations

Soon will be listed here.

Abstract

Doxycycline and minocycline are second-generation tetracyclines. They are readily absorbed, distributed throughout the organism as a function of their lipophilicity and eliminated in both the urine and the faeces. The influence of age, renal disease, malnutrition and hyperlipidaemia is reviewed, together with the main pharmacokinetic interactions.

Citing Articles

Increased usage of doxycycline for young children with Lyme disease.

Thompson A, Neville D, Chapman L, Balamuth F, Ladell M, Kharbanda A Front Antibiot. 2025; 3():1388039.

PMID: 39816267 PMC: 11732018. DOI: 10.3389/frabi.2024.1388039.

Generalized type II minocycline-induced pigmentation: A case report.

Zhao W, Fu H, Xu T, Shan S SAGE Open Med Case Rep. 2024; 12:2050313X241297214.

PMID: 39564131 PMC: 11574909. DOI: 10.1177/2050313X241297214.

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infections: The Current Landscape and Future Directions.

Allan-Blitz L, Mayer K Curr HIV/AIDS Rep. 2024; 22(1):1.

PMID: 39476167 DOI: 10.1007/s11904-024-00709-w.

Severe Discoloration of the Alveolar Bone Secondary to Long-Term Minocycline Therapy: A Case Report.

Friedl R, Jackson T, Dinh T, Yoon T Cureus. 2024; 16(7):e64672.

PMID: 39149683 PMC: 11326716. DOI: 10.7759/cureus.64672.

Comparative Evaluation of Antimicrobial Efficacy of Triple Antibiotic Paste Herbal Combination and Camphorated Monochlorophenol as Intracanal Medicaments against in Deciduous Molars: An Study.

Tawde M, Lakade L, Patil S, Kamble A, Patel A, Jajoo S Int J Clin Pediatr Dent. 2024; 17(3):243-254.

PMID: 39144514 PMC: 11320782. DOI: 10.5005/jp-journals-10005-2768.

References

Jonas M, Cunha B . Minocycline. Ther Drug Monit. 1982; 4(2):137-45. View

Raghuram T, Krishnaswamy K . Pharmacokinetics and plasma steady state levels of doxycycline in undernutrition. Br J Clin Pharmacol. 1982; 14(6):785-9. PMC: 1427538. DOI: 10.1111/j.1365-2125.1982.tb02037.x. View

Smith C, Woods C, Woods M . Absorption of minocycline. J Antimicrob Chemother. 1984; 13(1):93. DOI: 10.1093/jac/13.1.93. View

WHELTON A, Blanco L, Carter G, Craig T, Bryant H, Herbst D . Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract. Obstet Gynecol. 1980; 55(1):28-32. View

ZECH P . [Use of doxycycline in human renal failure]. Nouv Presse Med. 1980; 9(21 Suppl):82-3. View

Rogers J, Barnwell P, WATERMAN N, Austin F, Raff M . Clinical evaluation of intravenous minocycline. Int J Clin Pharmacol Biopharm. 1977; 15(4):194-8. View

Mattila M, Laisi U, Linnoila M, Salonen R . Effect of alcoholic beverages on the pharmacokinetics of doxycycline in man. Acta Pharmacol Toxicol (Copenh). 1982; 50(5):370-3. DOI: 10.1111/j.1600-0773.1982.tb00989.x. View

Barling R, Selkon J . The penetration of antibiotics into cerebrospinal fluid and brain tissue. J Antimicrob Chemother. 1978; 4(3):203-27. DOI: 10.1093/jac/4.3.203. View

Wojcicki J, Kalinowski W, Gawronska-Szklarz B . Comparative pharmacokinetics of doxycycline and oxytetracycline in patients with hyperlipidemia. Arzneimittelforschung. 1985; 35(6):991-3. View

10.

Saux M, Mosser J, Pontagnier H, Leng B . Pharmacokinetics of doxycycline polyphosphate after oral multiple dosing in humans. Eur J Drug Metab Pharmacokinet. 1982; 7(2):123-30. DOI: 10.1007/BF03188729. View

11.

Saux M, Mosser J, Pontagnier H, Leng B . Pharmacokinetic study of doxycycline polyphosphate (PPD), hydrochloride (CHD) and base (DB). Eur J Drug Metab Pharmacokinet. 1981; 6(1):3-10. DOI: 10.1007/BF03189510. View

12.

Schreiner A, Digranes A . Pharmacokinetics of lymecycline and doxycycline in serum and suction blister fluid. Chemotherapy. 1985; 31(4):261-5. DOI: 10.1159/000238345. View

13.

Brihmer C, BRUNDIN J . Doxycycline in human oviduct mucosa and plasma 24-30 hours after an oral dose of 100 mg. Acta Obstet Gynecol Scand. 1985; 64(6):529-30. DOI: 10.3109/00016348509156734. View

14.

Carney S, Butcher R, DAWBORN J, Pattison G . Minocycline excretion and distribution in relation to renal function in man. Clin Exp Pharmacol Physiol. 1974; 1(4):299-308. DOI: 10.1111/j.1440-1681.1974.tb00552.x. View

15.

Jonkman J, van der Boon W, Schoenmaker R, Holtkamp A, Hempenius J . No influence of doxycycline on theophylline pharmacokinetics. Ther Drug Monit. 1985; 7(1):92-4. DOI: 10.1097/00007691-198503000-00016. View

16.

Le Verge R, Javaudin L, Guesnier L, TREBAUL L . [Pharmacokinetic study of minocycline after venous perfusion in the human]. Therapie. 1976; 31(1):105-19. View

17.

Sklenar I, Spring P, DETTLI L . One-dose and multiple-dose kinetics of minocycline in patients with renal disease. Agents Actions. 1977; 7(3):369-77. DOI: 10.1007/BF01969570. View

18.

Marlin G, Cheng S, Thompson P . Sputum and plasma doxycycline concentrations after a single oral 600 mg doxycycline dose in patients with chronic bronchitis. Eur J Respir Dis. 1981; 62(4):276-80. View

19.

WHELTON A . [Use of tetracyclines during renal failure]. Nouv Presse Med. 1980; 9(21 Suppl):86-92. View

20.

Blanchard P, RUDHARDT M, Fabre J . Behaviour of doxycycline in the tissues. Chemotherapy. 1975; 21 Suppl 1:8-18. DOI: 10.1159/000221886. View